[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Page 5478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02870]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and has been 
granted registration by the Drug Enforcement Administration (DEA) as an 
importer of schedule II controlled substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as an importer of a basic class of controlled substance. 
Information on the previously published notice is listed in the table 
below. No comments or objections were submitted and no requests for 
hearing were submitted for this notice.

------------------------------------------------------------------------
            Company                FR docket           Published
------------------------------------------------------------------------
Myoderm........................   83 FR 66751  December 27, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrant to 
import the applicable basic class of schedule II controlled substances 
is consistent with the public interest and with United States 
obligations under international treaties, conventions, or protocols in 
effect on May 1, 1971. The DEA investigated the company's maintenance 
of effective controls against diversion by inspecting and testing the 
company's physical security systems, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule II controlled substances to the above listed 
company.

    Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02870 Filed 2-20-19; 8:45 am]
 BILLING CODE 4410-09-P